Jim Cramer's 'Market Is Dead Wrong' Call: Opportunities in GE, Wells Fargo and J&J

Jim Cramer, on "Mad Money", argued that the market is 'dead wrong' about several blue‑chip stocks and highlighted five oversold names worthy of attention.

GE Aerospace: Guidance Raise Met With Selling

■GE Aerospace posted adjusted EPS of $2.02, beating the $1.86 consensus by 9%.

■Revenue rose to $13.35 billion, up 21.1% YoY.

■Free cash flow jumped 43% to $3.03 billion.

■Full‑year EPS guidance lifted to $7.65‑$7.85.

■Backlog exceeds $210 billion.

Wells Fargo: A ‘Steal’ at 12× Earnings

■Wells Fargo Q1 2026 diluted EPS $1.60 on revenue of $21.446 billion.

■$4.0 billion in share buybacks; medium‑term ROCE target raised to 17‑18%.

■Under CEO Charlie Scharf, Markets revenue up 19% and Wealth & Investment Management client assets reached $2.2 trillion.

Johnson & Johnson: Heart‑Unit Miss vs. TREMFYA Surge

■JNJ shares slipped $8 after a minor heart‑unit miss.

■TREMFYA sales surged 68%.

■The company logged its 64th consecutive dividend increase.

Daily Market Moves: Dow, S&P 500 and Nasdaq

■The Dow Jones fell 106 points.

■The S&P 500 declined 0.51%.

■The Nasdaq dropped 1.47%.

Ege Kaan: With VIX subdued by short‑term gamma‑squeeze dynamics, the market is overlooking fundamentals. The sell‑off of quality names such as GE and Wells Fargo creates a dislocation that should reverse as earnings season progresses. These deeply oversold levels present a window for institutional buyers to re‑engage.